CCBs vs ACE inhibitors in patients with diabetes

J Fam Pract. 1998 Jul;47(1):12-3.
No abstract available

Publication types

  • Clinical Trial
  • Comparative Study
  • Randomized Controlled Trial

MeSH terms

  • Amlodipine / adverse effects*
  • Amlodipine / therapeutic use
  • Angiotensin-Converting Enzyme Inhibitors / adverse effects*
  • Angiotensin-Converting Enzyme Inhibitors / therapeutic use
  • Antihypertensive Agents / adverse effects*
  • Antihypertensive Agents / therapeutic use
  • Calcium Channel Blockers / adverse effects*
  • Calcium Channel Blockers / therapeutic use
  • Cardiovascular Diseases / chemically induced*
  • Cardiovascular Diseases / prevention & control
  • Diabetes Mellitus, Type 2 / drug therapy*
  • Diabetic Angiopathies / chemically induced*
  • Diabetic Angiopathies / prevention & control
  • Follow-Up Studies
  • Fosinopril / adverse effects*
  • Fosinopril / therapeutic use
  • Humans
  • Hypertension / drug therapy*
  • Risk Factors
  • Treatment Outcome

Substances

  • Angiotensin-Converting Enzyme Inhibitors
  • Antihypertensive Agents
  • Calcium Channel Blockers
  • Amlodipine
  • Fosinopril